NICE backs Pradaxa for stroke prevention
LONDON (Reuters) – Healthcare cost-effectiveness watchdog NICE has recommended the use of Boehringer Ingelheim’s new anti-clotting pill Pradaxa, after getting additional information on the medicine from the company.
NICE backs Pradaxa for stroke prevention
November 1, 2011 By
